DEF 14AThe Ballot
Damora Therapeutics, Inc. files DEF 14A
Filed Dec 31, 2025 · 6mo ago · Accession 0001140361-25-047056
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- DEF 14A
- Filing date
- Dec 31, 2025
- Report date
- Feb 9, 2026
- Document
- ny20059568x2_def14a.htm
- Size
- 7.5 MB